A New Chapter for AI in the Medical World: OpenAI's Specialized ChatGPT Arrives to Assist Doctors..

A visit to a hospital often presents a distinct scene: healthcare professionals—such as nurses, doctors, and physician assistants—constantly grappling with paperwork. This paperwork typically includes patient histories, referral letters, and summaries of lab reports. Now, AI is stepping in to assist healthcare professionals with this administrative burden. Until now, AI companies have been notably cautious regarding two specific domains: the first being politics, and the second, medicine (given that it directly involves the health and well-being of users). While AI companies continue to offer health-related advice to users with extreme caution, OpenAI has announced the launch of a new version of ChatGPT specifically designed for doctors. This new tool has been developed with physicians in mind, and the company claims it will prove invaluable in clinical tasks such as drafting documentation and conducting medical research.

OpenAI states that this model will enable doctors to "accelerate administrative tasks—such as medical research and documentation—thereby freeing up more time to dedicate to patient care." This tool is not intended to replace doctors, but rather aims to augment their capabilities. It can generate drafts that doctors can review, edit, and approve before they are formally incorporated into official medical records.

**The Shift from Experimental to Practical AI**
The launch of OpenAI Clinical is significant in that it signals a major paradigm shift. AI is now moving beyond purely experimental applications to become an integral part of practical, day-to-day operations. Instead of focusing solely on disease diagnosis or research, companies are now directing their efforts toward resolving the operational challenges encountered in the workplace—specifically, the burden of administrative paperwork. This shift has a direct and profound impact on the manner in which healthcare services are delivered.

**User Reactions to the New Tool**
Users across the internet have expressed a positive outlook toward this new tool, acknowledging and agreeing that doctors face an overwhelming administrative workload—tasks that include drafting referral letters, securing prior authorizations, and preparing explanatory documents for patients. This tool could also assist them in clinical research.

In a blog post, OpenAI stated: "According to a 2026 survey by the American Medical Association, AI adoption among physicians has reached an all-time high; 72% of doctors reported using AI in their clinical practice—up from 48% last year."

Raising the issue of privacy, an X user praised the tool:
"Doctors bogged down by administrative paperwork have finally found relief through AI. OpenAI has launched 'ChatGPT for Clinicians,' which is available for free to verified U.S. physicians, nurse practitioners, physician assistants, and pharmacists. This tool specifically targets healthcare providers grappling with staff shortages and heavy workloads. It offers quick access exclusively to verified users, free of any cost barriers.

This rollout has the potential to accelerate diagnostics, reduce paperwork, and transform workflows. However, access remains limited due to the verification process, and questions regarding data privacy in high-stakes medical settings persist."

**Benchmarks and Performance Claims**
OpenAI has also released HealthBench Professional—an open benchmark designed to evaluate interactions between AI models and actual physicians across the domains of clinical advice, writing and documentation, and medical research. The company reports that the specialized ChatGPT model for clinicians achieved an overall score of 59.0, while Claude Opus 4.7 scored 47. These results indicate that this model outperformed its competitors.

Disclaimer: This content has been sourced and edited from Dainik Jagran. While we have made modifications for clarity and presentation, the original content belongs to its respective authors and website. We do not claim ownership of the content.